SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-027323
Filing Date
2021-11-23
Accepted
2021-11-23 17:24:37
Documents
15
Period of Report
2021-11-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20211123_8k.htm   iXBRL 8-K 26111
2 EXHIBIT 99.1 ex_310643.htm EX-99.1 7203
7 logo.jpg GRAPHIC 10766
  Complete submission text file 0001437749-21-027323.txt   184060

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acrx-20211120.xsd EX-101.SCH 3594
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20211120_def.xml EX-101.DEF 11425
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20211120_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20211120_pre.xml EX-101.PRE 11585
8 EXTRACTED XBRL INSTANCE DOCUMENT acrx20211123_8k_htm.xml XML 2572
Mailing Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545
Business Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 211439854
SIC: 2834 Pharmaceutical Preparations